Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

World's Safety In Hands Of A Few Biotechs; Who Cares?

This article was originally published in Scrip

Executive Summary

The safety of the US, and even the rest of the world, against biological threats – either manmade or natural – rests in the hands of a relatively small number of biopharmaceutical companies, most of which are small private firms, whose investors are reluctant to stick around if there's an unclear regulatory pathway and an uncertain market for the products those firms produce, Jim Greenwood, president and CEO of the Biotechnology Innovation Organization, told a House subcommittee on Feb. 12.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064492

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel